Abstract:Aim: To assess the effect and mechanism of tumor necrosis factor-α (TNF-α) induced by bradykinin (BK) from glioma cells to an in vitro blood-tumor barrier. Methods: Radioimmunoassay was used to dynamically monitor the contents of TNF-α in nutrient fluid for C6 cells after BK treatment. In vitro blood-tumor barrier model was established, then the influence of conditioned medium of C6 that was treated by BK (C6CM) was observed on levels of mitogen-activated protein kinase (MAPK) mRNA by RT-PCR method for brain microvascular endothelial cell (BMEC), contents of nuclear transcription factor kappaB (NF-κB) was observed by immunohistochemistry, as well as permeability of blood-tumor barrier was detected by Evans blue. And immunofluorescence technique was used to detect the expression of occluding. Results: For C6 cells, contents of TNF-α in the nutrient fluid increased obviously after BK treatment, with the maximal achieved at 120 min. C6CM acted on in vitro blood-tumor barrier, levels of MAPK mRNA and contents of NF-κB were both decreased, and reached the maximum at 120 min. The expression of occluding showed the same trend. Conclusions: BK promotes C6 cell to release TNF-α, which decreases expression of NF-κB and levels of MAPK mRNA in BMEC, then reduces the expression of occluding. All these mechanisms may explain the effect of TNF-α on opening the blood-tumor barrier by BK.

Study of relation between bradykinin-induced blood-tumor barrier opening and TNF-α/MAPK/NF-κB